Sugar and alcohol molecules provide a therapeutic strategy for the serpinopathies that cause dementia and cirrhosis

Mutations in neuroserpin and α1‐antitrypsin cause these proteins to form ordered polymers that are retained within the endoplasmic reticulum of neurones and hepatocytes, respectively. The resulting inclusions underlie the dementia familial encephalopathy with neuroserpin inclusion bodies (FENIB) and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The FEBS journal 2006-06, Vol.273 (11), p.2450-2552
Hauptverfasser: Sharp, Lynda K., Mallya, Meera, Kinghorn, Kerri J., Wang, Zhen, Crowther, Damian C., Huntington, James A., Belorgey, Didier, Lomas, David A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2552
container_issue 11
container_start_page 2450
container_title The FEBS journal
container_volume 273
creator Sharp, Lynda K.
Mallya, Meera
Kinghorn, Kerri J.
Wang, Zhen
Crowther, Damian C.
Huntington, James A.
Belorgey, Didier
Lomas, David A.
description Mutations in neuroserpin and α1‐antitrypsin cause these proteins to form ordered polymers that are retained within the endoplasmic reticulum of neurones and hepatocytes, respectively. The resulting inclusions underlie the dementia familial encephalopathy with neuroserpin inclusion bodies (FENIB) and Z α1‐antitrypsin‐associated cirrhosis. Polymers form by a sequential linkage between the reactive centre loop of one molecule and β‐sheet A of another, and strategies that block polymer formation are likely to be successful in treating the associated disease. We show here that glycerol, the sugar alcohol erythritol, the disaccharide trehalose and its breakdown product glucose reduce the rate of polymerization of wild‐type neuroserpin and the Ser49Pro mutant that causes dementia. They also attenuate the polymerization of the Z variant of α1‐antitrypsin. The effect on polymerization was apparent even when these agents had been removed from the buffer. None of these agents had any detectable effect on the structure or inhibitory activity of neuroserpin or α1‐antitrypsin. These data demonstrate that sugar and alcohol molecules can reduce the polymerization of serpin mutants that cause disease, possibly by binding to and stabilizing β‐sheet A.
doi_str_mv 10.1111/j.1742-4658.2006.05262.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67977781</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67977781</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4262-9a37eb23bdd4e816a36ea1d6c2b75bf9f186f7a2f6c2d2f024e65a1cb80c2b8a3</originalsourceid><addsrcrecordid>eNqNkU9r3DAQxU1paf60X6GIHnpbV5JlyboU2pCkhUAPSaA3MZbHsRbbciU7zX77ytklhV4SXTTM_N6Dx8sywmjO0vu8zZkSfCNkWeWcUpnTkkueP7zKjp8Or59m8esoO4lxS2lRCq3fZkdMKioE08dZvF7uIBAYGwK99Z3vyeB7tEuPkUzB37sGCZC5wwATLrOzJM4BZrzbkdaH9UAihsmNfoK5c0k1dzATC0tE0uCA4-zg0d-6EDofXXyXvWmhj_j-8J9mtxfnN2ffN1c_L3-cfb3aWJHSbDQUCmte1E0jsGISConAGml5rcq61S2rZKuAt2nT8JZygbIEZuuKJqSC4jT7tPdNOX4vGGczuGix72FEv0QjlVZKVexZkClOhdQygR__A7d-CWMKYRLBqNZVkaBqD9ngYwzYmim4AcLOMGrW-szWrM2YtSWz1mce6zMPSfrh4L_UAzb_hIe-EvBlD_xxPe5ebGwuzr9dr2PxF6Lxq04</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>204109983</pqid></control><display><type>article</type><title>Sugar and alcohol molecules provide a therapeutic strategy for the serpinopathies that cause dementia and cirrhosis</title><source>MEDLINE</source><source>Wiley Journals</source><source>Wiley Free Content</source><source>IngentaConnect Free/Open Access Journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Sharp, Lynda K. ; Mallya, Meera ; Kinghorn, Kerri J. ; Wang, Zhen ; Crowther, Damian C. ; Huntington, James A. ; Belorgey, Didier ; Lomas, David A.</creator><creatorcontrib>Sharp, Lynda K. ; Mallya, Meera ; Kinghorn, Kerri J. ; Wang, Zhen ; Crowther, Damian C. ; Huntington, James A. ; Belorgey, Didier ; Lomas, David A.</creatorcontrib><description>Mutations in neuroserpin and α1‐antitrypsin cause these proteins to form ordered polymers that are retained within the endoplasmic reticulum of neurones and hepatocytes, respectively. The resulting inclusions underlie the dementia familial encephalopathy with neuroserpin inclusion bodies (FENIB) and Z α1‐antitrypsin‐associated cirrhosis. Polymers form by a sequential linkage between the reactive centre loop of one molecule and β‐sheet A of another, and strategies that block polymer formation are likely to be successful in treating the associated disease. We show here that glycerol, the sugar alcohol erythritol, the disaccharide trehalose and its breakdown product glucose reduce the rate of polymerization of wild‐type neuroserpin and the Ser49Pro mutant that causes dementia. They also attenuate the polymerization of the Z variant of α1‐antitrypsin. The effect on polymerization was apparent even when these agents had been removed from the buffer. None of these agents had any detectable effect on the structure or inhibitory activity of neuroserpin or α1‐antitrypsin. These data demonstrate that sugar and alcohol molecules can reduce the polymerization of serpin mutants that cause disease, possibly by binding to and stabilizing β‐sheet A.</description><identifier>ISSN: 1742-464X</identifier><identifier>EISSN: 1742-4658</identifier><identifier>DOI: 10.1111/j.1742-4658.2006.05262.x</identifier><identifier>PMID: 16704419</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Alcohol ; alpha 1-Antitrypsin - chemistry ; alpha 1-Antitrypsin - drug effects ; Carbohydrates - therapeutic use ; Circular Dichroism ; Dementia ; Dementia - drug therapy ; Erythritol - pharmacology ; Ethanol - therapeutic use ; FENIB ; Glucose - pharmacology ; Glycerol - pharmacology ; Liver cirrhosis ; Liver Cirrhosis - drug therapy ; Models, Molecular ; Mutation ; Neuropeptides - drug effects ; Neuropeptides - metabolism ; Neuroserpin ; Polymerization ; Protein Conformation ; Protein Structure, Secondary ; Recombinant Proteins - drug effects ; Recombinant Proteins - metabolism ; serpinopathy ; Serpins - drug effects ; Serpins - metabolism ; Sugar ; Trehalose - pharmacology ; α1‐antitrypsin</subject><ispartof>The FEBS journal, 2006-06, Vol.273 (11), p.2450-2552</ispartof><rights>2006 The Authors Journal compilation 2006 FEBS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4262-9a37eb23bdd4e816a36ea1d6c2b75bf9f186f7a2f6c2d2f024e65a1cb80c2b8a3</citedby><cites>FETCH-LOGICAL-c4262-9a37eb23bdd4e816a36ea1d6c2b75bf9f186f7a2f6c2d2f024e65a1cb80c2b8a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1742-4658.2006.05262.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1742-4658.2006.05262.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16704419$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sharp, Lynda K.</creatorcontrib><creatorcontrib>Mallya, Meera</creatorcontrib><creatorcontrib>Kinghorn, Kerri J.</creatorcontrib><creatorcontrib>Wang, Zhen</creatorcontrib><creatorcontrib>Crowther, Damian C.</creatorcontrib><creatorcontrib>Huntington, James A.</creatorcontrib><creatorcontrib>Belorgey, Didier</creatorcontrib><creatorcontrib>Lomas, David A.</creatorcontrib><title>Sugar and alcohol molecules provide a therapeutic strategy for the serpinopathies that cause dementia and cirrhosis</title><title>The FEBS journal</title><addtitle>FEBS J</addtitle><description>Mutations in neuroserpin and α1‐antitrypsin cause these proteins to form ordered polymers that are retained within the endoplasmic reticulum of neurones and hepatocytes, respectively. The resulting inclusions underlie the dementia familial encephalopathy with neuroserpin inclusion bodies (FENIB) and Z α1‐antitrypsin‐associated cirrhosis. Polymers form by a sequential linkage between the reactive centre loop of one molecule and β‐sheet A of another, and strategies that block polymer formation are likely to be successful in treating the associated disease. We show here that glycerol, the sugar alcohol erythritol, the disaccharide trehalose and its breakdown product glucose reduce the rate of polymerization of wild‐type neuroserpin and the Ser49Pro mutant that causes dementia. They also attenuate the polymerization of the Z variant of α1‐antitrypsin. The effect on polymerization was apparent even when these agents had been removed from the buffer. None of these agents had any detectable effect on the structure or inhibitory activity of neuroserpin or α1‐antitrypsin. These data demonstrate that sugar and alcohol molecules can reduce the polymerization of serpin mutants that cause disease, possibly by binding to and stabilizing β‐sheet A.</description><subject>Alcohol</subject><subject>alpha 1-Antitrypsin - chemistry</subject><subject>alpha 1-Antitrypsin - drug effects</subject><subject>Carbohydrates - therapeutic use</subject><subject>Circular Dichroism</subject><subject>Dementia</subject><subject>Dementia - drug therapy</subject><subject>Erythritol - pharmacology</subject><subject>Ethanol - therapeutic use</subject><subject>FENIB</subject><subject>Glucose - pharmacology</subject><subject>Glycerol - pharmacology</subject><subject>Liver cirrhosis</subject><subject>Liver Cirrhosis - drug therapy</subject><subject>Models, Molecular</subject><subject>Mutation</subject><subject>Neuropeptides - drug effects</subject><subject>Neuropeptides - metabolism</subject><subject>Neuroserpin</subject><subject>Polymerization</subject><subject>Protein Conformation</subject><subject>Protein Structure, Secondary</subject><subject>Recombinant Proteins - drug effects</subject><subject>Recombinant Proteins - metabolism</subject><subject>serpinopathy</subject><subject>Serpins - drug effects</subject><subject>Serpins - metabolism</subject><subject>Sugar</subject><subject>Trehalose - pharmacology</subject><subject>α1‐antitrypsin</subject><issn>1742-464X</issn><issn>1742-4658</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU9r3DAQxU1paf60X6GIHnpbV5JlyboU2pCkhUAPSaA3MZbHsRbbciU7zX77ytklhV4SXTTM_N6Dx8sywmjO0vu8zZkSfCNkWeWcUpnTkkueP7zKjp8Or59m8esoO4lxS2lRCq3fZkdMKioE08dZvF7uIBAYGwK99Z3vyeB7tEuPkUzB37sGCZC5wwATLrOzJM4BZrzbkdaH9UAihsmNfoK5c0k1dzATC0tE0uCA4-zg0d-6EDofXXyXvWmhj_j-8J9mtxfnN2ffN1c_L3-cfb3aWJHSbDQUCmte1E0jsGISConAGml5rcq61S2rZKuAt2nT8JZygbIEZuuKJqSC4jT7tPdNOX4vGGczuGix72FEv0QjlVZKVexZkClOhdQygR__A7d-CWMKYRLBqNZVkaBqD9ngYwzYmim4AcLOMGrW-szWrM2YtSWz1mce6zMPSfrh4L_UAzb_hIe-EvBlD_xxPe5ebGwuzr9dr2PxF6Lxq04</recordid><startdate>200606</startdate><enddate>200606</enddate><creator>Sharp, Lynda K.</creator><creator>Mallya, Meera</creator><creator>Kinghorn, Kerri J.</creator><creator>Wang, Zhen</creator><creator>Crowther, Damian C.</creator><creator>Huntington, James A.</creator><creator>Belorgey, Didier</creator><creator>Lomas, David A.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>200606</creationdate><title>Sugar and alcohol molecules provide a therapeutic strategy for the serpinopathies that cause dementia and cirrhosis</title><author>Sharp, Lynda K. ; Mallya, Meera ; Kinghorn, Kerri J. ; Wang, Zhen ; Crowther, Damian C. ; Huntington, James A. ; Belorgey, Didier ; Lomas, David A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4262-9a37eb23bdd4e816a36ea1d6c2b75bf9f186f7a2f6c2d2f024e65a1cb80c2b8a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Alcohol</topic><topic>alpha 1-Antitrypsin - chemistry</topic><topic>alpha 1-Antitrypsin - drug effects</topic><topic>Carbohydrates - therapeutic use</topic><topic>Circular Dichroism</topic><topic>Dementia</topic><topic>Dementia - drug therapy</topic><topic>Erythritol - pharmacology</topic><topic>Ethanol - therapeutic use</topic><topic>FENIB</topic><topic>Glucose - pharmacology</topic><topic>Glycerol - pharmacology</topic><topic>Liver cirrhosis</topic><topic>Liver Cirrhosis - drug therapy</topic><topic>Models, Molecular</topic><topic>Mutation</topic><topic>Neuropeptides - drug effects</topic><topic>Neuropeptides - metabolism</topic><topic>Neuroserpin</topic><topic>Polymerization</topic><topic>Protein Conformation</topic><topic>Protein Structure, Secondary</topic><topic>Recombinant Proteins - drug effects</topic><topic>Recombinant Proteins - metabolism</topic><topic>serpinopathy</topic><topic>Serpins - drug effects</topic><topic>Serpins - metabolism</topic><topic>Sugar</topic><topic>Trehalose - pharmacology</topic><topic>α1‐antitrypsin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sharp, Lynda K.</creatorcontrib><creatorcontrib>Mallya, Meera</creatorcontrib><creatorcontrib>Kinghorn, Kerri J.</creatorcontrib><creatorcontrib>Wang, Zhen</creatorcontrib><creatorcontrib>Crowther, Damian C.</creatorcontrib><creatorcontrib>Huntington, James A.</creatorcontrib><creatorcontrib>Belorgey, Didier</creatorcontrib><creatorcontrib>Lomas, David A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The FEBS journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sharp, Lynda K.</au><au>Mallya, Meera</au><au>Kinghorn, Kerri J.</au><au>Wang, Zhen</au><au>Crowther, Damian C.</au><au>Huntington, James A.</au><au>Belorgey, Didier</au><au>Lomas, David A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sugar and alcohol molecules provide a therapeutic strategy for the serpinopathies that cause dementia and cirrhosis</atitle><jtitle>The FEBS journal</jtitle><addtitle>FEBS J</addtitle><date>2006-06</date><risdate>2006</risdate><volume>273</volume><issue>11</issue><spage>2450</spage><epage>2552</epage><pages>2450-2552</pages><issn>1742-464X</issn><eissn>1742-4658</eissn><abstract>Mutations in neuroserpin and α1‐antitrypsin cause these proteins to form ordered polymers that are retained within the endoplasmic reticulum of neurones and hepatocytes, respectively. The resulting inclusions underlie the dementia familial encephalopathy with neuroserpin inclusion bodies (FENIB) and Z α1‐antitrypsin‐associated cirrhosis. Polymers form by a sequential linkage between the reactive centre loop of one molecule and β‐sheet A of another, and strategies that block polymer formation are likely to be successful in treating the associated disease. We show here that glycerol, the sugar alcohol erythritol, the disaccharide trehalose and its breakdown product glucose reduce the rate of polymerization of wild‐type neuroserpin and the Ser49Pro mutant that causes dementia. They also attenuate the polymerization of the Z variant of α1‐antitrypsin. The effect on polymerization was apparent even when these agents had been removed from the buffer. None of these agents had any detectable effect on the structure or inhibitory activity of neuroserpin or α1‐antitrypsin. These data demonstrate that sugar and alcohol molecules can reduce the polymerization of serpin mutants that cause disease, possibly by binding to and stabilizing β‐sheet A.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>16704419</pmid><doi>10.1111/j.1742-4658.2006.05262.x</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1742-464X
ispartof The FEBS journal, 2006-06, Vol.273 (11), p.2450-2552
issn 1742-464X
1742-4658
language eng
recordid cdi_proquest_miscellaneous_67977781
source MEDLINE; Wiley Journals; Wiley Free Content; IngentaConnect Free/Open Access Journals; Free Full-Text Journals in Chemistry
subjects Alcohol
alpha 1-Antitrypsin - chemistry
alpha 1-Antitrypsin - drug effects
Carbohydrates - therapeutic use
Circular Dichroism
Dementia
Dementia - drug therapy
Erythritol - pharmacology
Ethanol - therapeutic use
FENIB
Glucose - pharmacology
Glycerol - pharmacology
Liver cirrhosis
Liver Cirrhosis - drug therapy
Models, Molecular
Mutation
Neuropeptides - drug effects
Neuropeptides - metabolism
Neuroserpin
Polymerization
Protein Conformation
Protein Structure, Secondary
Recombinant Proteins - drug effects
Recombinant Proteins - metabolism
serpinopathy
Serpins - drug effects
Serpins - metabolism
Sugar
Trehalose - pharmacology
α1‐antitrypsin
title Sugar and alcohol molecules provide a therapeutic strategy for the serpinopathies that cause dementia and cirrhosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T12%3A49%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sugar%20and%20alcohol%20molecules%20provide%20a%20therapeutic%20strategy%20for%20the%20serpinopathies%20that%20cause%20dementia%20and%20cirrhosis&rft.jtitle=The%20FEBS%20journal&rft.au=Sharp,%20Lynda%20K.&rft.date=2006-06&rft.volume=273&rft.issue=11&rft.spage=2450&rft.epage=2552&rft.pages=2450-2552&rft.issn=1742-464X&rft.eissn=1742-4658&rft_id=info:doi/10.1111/j.1742-4658.2006.05262.x&rft_dat=%3Cproquest_cross%3E67977781%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=204109983&rft_id=info:pmid/16704419&rfr_iscdi=true